UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort

American journal of hematology, 2016-04, Vol.91 (4), p.395-399

2016

Volltextzugriff (PDF)

Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

Current hematologic malignancy reports, 2013-09, Vol.8 (3), p.173-183

2013

Volltextzugriff (PDF)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma

Advances in Hematology, 2014, Vol.2014 (2014), p.100-111

2014

Volltextzugriff (PDF)

Immunotherapy Management in Special Cancer Patient Populations

JCO oncology practice, 2021-05, Vol.17 (5), p.240-245

2021

Volltextzugriff (PDF)

Pericardial Effusion: A Novel Presentation of Aplastic Anemia

Curēus (Palo Alto, CA), 2023-01

2023

Volltextzugriff (PDF)

Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient?

Drugs & aging, 2019-01, Vol.36 (1), p.1-11

2019

Volltextzugriff (PDF)

Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns

Drugs & aging, 2018-12, Vol.35 (12), p.1055-1064

2018

Volltextzugriff (PDF)

A Comprehensive Model for Predicting 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Older Patients

Blood, 2023-11, Vol.142 (Supplement 1), p.7099-7099

2023

Volltextzugriff (PDF)

Gut Microbiome Faecalibacterium Abundance in Patients with Plasma Cell Disorders Undergoing Autologous Hematopoietic Stem Cell Transplant Is Associated with Progression Free Survival

Blood, 2023-11, Vol.142 (Supplement 1), p.3596-3596

2023

Volltextzugriff (PDF)

Acute myeloid leukemia (AML) outcomes in the era of novel therapies: A 9-year single-institution experience

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e19053-e19053

2023

Volltextzugriff (PDF)

Racial, Ethnic and Socioeconomic Disparity in Outcomes of Patients with Chronic Graft-Versus-Host Disease: A CIBMTR Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.5108-5109

2022

Volltextzugriff (PDF)

Locally advanced cervical cancer: what is the standard of care?

Current opinion in oncology, 2010-09, Vol.22 (5), p.503-512

2010

Volltextzugriff (PDF)

Global research productivity of post-transplant lymphoproliferative disorder: a bibliometric study

Annals of medicine and surgery, 2024-03, Vol.86 (3), p.1522-1530

2024

Volltextzugriff (PDF)

A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia

Leukemia & lymphoma, 2024-10, Vol.65 (10), p.1502-1510

2024

Volltextzugriff (PDF)

Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation

Journal of clinical oncology, 2022-03, Vol.40 (7), p.772-783

2022

Volltextzugriff (PDF)

Distress, Health-Related Quality of Life (HQOL) and Confidence in Survivorship Information (CSI) in Older (≥60 Years) Hematopoietic Cell Transplant (HCT) Patients

Blood, 2021-11, Vol.138 (Supplement 1), p.426-426

2021

Volltextzugriff (PDF)

Cancer and Treatment Distress (CTXD) and Confidence in Survivorship Information (CSI) Trends in Older (≥60 Years) Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Survivors

Blood, 2021-11, Vol.138 (Supplement 1), p.4123-4123

2021

Volltextzugriff (PDF)

Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors

Blood, 2021-11, Vol.138 (Supplement 1), p.3932-3932

2021

Volltextzugriff (PDF)

A phase 1b/2 study of TP-0903 and decitabine targeting mutant TP53 and/or complex karyotype in patients with untreated acute myeloid leukemia ≥ age 60 years: Phase 1b interim results

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7027-7027

2022

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(72)
Buchkapitel
(2)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(14)
Hematology
(11)
Aged
(9)
Male
(8)
Oncology
(8)
Adult
(7)
Female
(7)
Hematology, Oncology And Palliative Medicine
(7)
Middle Aged
(7)
Transplantation
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Patients
(5)
Quality Of Life
(5)
Chemotherapy
(4)
Hematopoietic Cell Transplantation
(4)
Immunology
(4)
Lymphoma, Large B-Cell, Diffuse - Mortality
(4)
Prognosis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort

P512: A PHASE 1B/2 STUDY OF TP‐0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS

Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma

Diffuse large B‐cell lymphoma with primary treatment failure: Ultra‐high risk features and benchmarking for experimental therapies

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B‐cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort

C‐MYC–positive relapsed and refractory, diffuse large B‐cell lymphoma: Impact of additional “hits” and outcomes with subsequent therapy

Immunotherapy Management in Special Cancer Patient Populations

Pericardial Effusion: A Novel Presentation of Aplastic Anemia

Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient?

Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns

A Comprehensive Model for Predicting 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Older Patients

Gut Microbiome Faecalibacterium Abundance in Patients with Plasma Cell Disorders Undergoing Autologous Hematopoietic Stem Cell Transplant Is Associated with Progression Free Survival

Acute myeloid leukemia (AML) outcomes in the era of novel therapies: A 9-year single-institution experience

Racial, Ethnic and Socioeconomic Disparity in Outcomes of Patients with Chronic Graft-Versus-Host Disease: A CIBMTR Analysis

Locally advanced cervical cancer: what is the standard of care?

Global research productivity of post-transplant lymphoproliferative disorder: a bibliometric study

A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia

Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation

Distress, Health-Related Quality of Life (HQOL) and Confidence in Survivorship Information (CSI) in Older (≥60 Years) Hematopoietic Cell Transplant (HCT) Patients

Cancer and Treatment Distress (CTXD) and Confidence in Survivorship Information (CSI) Trends in Older (≥60 Years) Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Survivors

Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors

A phase 1b/2 study of TP-0903 and decitabine targeting mutant TP53 and/or complex karyotype in patients with untreated acute myeloid leukemia ≥ age 60 years: Phase 1b interim results

A Phase 1b Dose Escalation and Expansion Study of SNDX-5613, Azacitidine (AZA) and Venetoclax (VEN) in Newly Diagnosed, Patients ≥ 60 Years with Untreated NPM1-Mutated/ FLT3-Wild Type AML or KMT2A-Rearranged Acute Myeloid Leukemia (AML)

Suchergebnisse filtern